Notch2-induced COX-2 expression enhancing gastric cancer progression

Molecular Carcinogenesis

Volumn 51, Issue 12, 2012, Pages 939-951

  Tseng, Yun Chien ^a   Tsai, Yu Hui ^b   Tseng, Min Jen ^c   Hsu, Kai Wen ^a   Yang, Min Chieh ^a   Huang, Kuo Hung ^a,d   Li, Anna Fen Yau ^a   Chi, Chin Wen ^a,d   Hsieh, Rong Hong ^b   Ku, Hung Hai ^a   Yeh, Tien Shun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

COX 2; Gastric cancer; Notch2 receptor; Tumorigenesis

Indexed keywords

CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NOTCH2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; WOUND HEALING;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH2; STOMACH NEOPLASMS;

MAMMALIA;

EID: 84867745527     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20865     Document Type: Article

References (68)

1. Executive Yuan. Taiwan area: Death rate of ten leading sites of malignant neoplasms. Taiwan, Department of Health, Executive Yuan 2006; pp. 160-173.
2. Terry M, Gaudet M, Gammon M. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12: 111-127.
3. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004; 5: 121-125.
4. Gonzalez C, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260.
5. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7: 61-77.
6. Smith M, Hold G, Tahara E, El-Omar E. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 2979-2990.
7. El-Rifai W, Powell S. Molecular biology of gastric cancer. Semin Radiat Oncol 2002; 12: 128-140.
8. Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin-active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 2006; 6: 936-946.
9. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107: 2223-2233.
10. Koch U, Radtke F. Notch and cancer: A double-edged sword. Cell Mol Life Sci 2007; 64: 2746-2762.
11. Radtke F, Raj K. The role of Notch in tumorigenesis: Oncogene or tumour suppressor? Nat Rev Cancer 2003; 3: 756-767.
12. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007; 6: 832-839.
13. Lowy AM, Clements WM, Bishop J, et al β-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006; 66: 4734-4741.
14. Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33: 416-421.
15. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276-1280.
16. Uefuji K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol 1998; 69: 168-172.
17. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999; 84: 400-403.
18. Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000; 6: 519-525.
19. Ohno R, Yoshinaga K, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91: 1876-1881.
20. Shi H, Xu J, Hu N, Xie H. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 2003; 9: 1421-1426.
21. Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999; 94: 451-455.
22. Chen JH, Wu CW, Kao HL, et al. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Lett 2006; 239: 263-270.
23. 2-dependent mechanisms. Carcinogenesis 2008; 29: 2227-2235.
24. Yeh TS, Wu CW, Hsu KW, et al. The activated Notch1 signal pathway is associated with gastric cancer progression through COX-2. Cancer Res 2009; 69: 5039-5048.
25. Hsu KW, Hsieh RH, Wu CW, et al. MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. Mol Biol Cell 2009; 20: 5127-5137.
26. Hu P, Yu J, Zeng Z, et al. Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004; 53: 195-200.
27. Lee D, Moss S. COX-2 inhibition and the prevention of gastric cancer. Digestion 2006; 74: 184-186.
28. Jiang X, Wong B. Cyclooxygenase-2 inhibition and gastric cancer. Curr Pharm Des 2003; 9: 2281-2288.
29. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience. World J Gastroenterol 2006; 12: 1336-1345.
30. Saukkonen K, Tomasetto C, Narko K, Rio M, Ristimäki A. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice. Cancer Res 2003; 63: 3032-3036.
31. O'Neill CF, Urs S, Cinelli C, et al. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol 2007; 171: 1023-1036.
32. Yin L, Velazquez OC, Liu ZJ. Notch signaling: Emerging molecular targets for cancer therapy. Biochem Pharmacol 2010; 80: 690-701.
33. Su JL, Shih JY, Yen ML, et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: A novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 2004; 64: 554-564.
34. Yeh TS, Lin YM, Hsieh RH, Tseng MJ. Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J Biol Chem 2003; 278: 41963-41969.
35. Wang AM, Ku HH, Liang YC, et al. The autonomous Notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem 2009; 106: 682-692.
36. Hsu KW, Hsieh RH, Lee YHW, et al. The activated Notch1 receptor cooperates with α-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol 2008; 28: 4829-4842.
37. Liao WR, Hsieh RH, Hsu KW, et al. The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogenesis 2007; 28: 1867-1876.
38. Hirata H, Yoshiura S, Ohtsuka T, et al. Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop. Science 2002; 298: 840-843.
39. Levens DL. Reconstructing Myc. Genes Dev 2003; 17: 1071-1077.
40. Weber A, Liu J, Collins I, Levens D. TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 2005; 25: 147-161.
41. Rao P, Kadesch T. The intracellular form of Notch blocks transforming growth factor β-mediated growth arrest in Mv1Lu epithelial cells. Mol Cell Biol 2003; 23: 6694-6701.
42. Satoh Y, Matsumura I, Tanaka H, et al. Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem 2004; 279: 24986-24993.
43. Klinakis A, Szabolcs M, Politi K, Kiaris H, Artavanis-Tsakonas S, Efstratiadis A. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA 2006; 103: 9262-9267.
44. Weng AP, Millholland JM, Yashiro-Ohtani Y, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006; 20: 2096-2109.
45. Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261-18266.
46. Sharma VM, Calvo JA, Draheim KM, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc Mol Cell Biol 2006; 26: 8022-8031.
47. Ray R. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ 1995; 6: 1089-1096.
48. Chaudhary D, Miller DM. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry 1995; 34: 3438-3445.
49. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: Relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 2000; 473: 47-52.
50. Ray R, Miller D. Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 1991; 11: 2154-2161.
51. Subramanian A, Miller DM. Structural analysis of alpha-enolase. mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 2000; 275: 5958-5965.
52. Fukushima H, Nakao A, Okamoto F, et al. The association of Notch2 and NF-κB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol 2008; 28: 6402-6412.
53. Tchorz JS, Kinter J, Müller M, Tornillo L, Heim MH, Bettler B. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice. Hepatology 2009; 50: 871-879.
54. Quillard T, Devalliere J, Chatelais M, et al. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule surviving. PLoS ONE 2009; 4: e8244.
55. de Moraes E, Dar N, de Moura Gallo C, Hainaut P. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis. Inter J Cancer 2007; 121: 929-937.
56. Wang D, Mann J, DuBois R. WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle 2004; 3: 1512-1515.
57. Lim JW, Kim H, Kim KH. Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest 2001; 81: 349-360.
58. Espinosa L, Ingles-Esteve J, Robert-Moreno A, Bigas A. IκBα and p65 regulate the cytoplasmic shuttling of nuclear corepressors: Cross-talk between Notch and NF-κB pathways. Mol Biol Cell 2003; 14: 491-502.
59. Ganapati U, Tan HT, Lynch M, Dolezal M, de Vos S, Gasson JC. Modeling Notch signaling in normal and neoplastic hematopoiesis: Global gene expression profiling in response to activated notch expression. Stem Cells 2007; 25: 1872-1880.
60. Hajdu M, Luttun A, Pelacho B, et al. Transcriptional characterization of the Notch signaling pathway in rodent multipotent adult progenitor cells. Pathol Oncol Res 2007; 13: 302-310.
61. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002; 8: 979-986.
62. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000; 14: 1343-1352.
63. Shimizu K, Chiba S, Saito T, Kumano K, Hamada Y, Hirai H. Functional diversity among Notch1, Notch2, and Notch3 receptors. Biochem Biophys Res Commun 2002; 291: 775-779.
64. Beatus P, Lundkvist J, Oberg C, Lendahl U. The Notch 3 intracellular domain represses Notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. Development 1999; 126: 3925-3935.
65. Ong CT, Cheng HT, Chang LW, et al. Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J Biol Chem 2006; 281: 5106-5119.
66. Graziani I, Eliasz S, De Marco MA, et al. Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res 2008; 68: 9678-9685.
67. Qiao L, Wong BCY. Role of Notch signaling in colorectal cancer. Carcinogenesis 2009; 30: 1979-1986.
68. Katoh M, Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol 2007; 30: 247-251.